Page last updated: 2024-11-07

penicillamine and Granulomatous Disease, Chronic

penicillamine has been researched along with Granulomatous Disease, Chronic in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lärfars, G1
Gyllenhammar, H1

Other Studies

1 other study available for penicillamine and Granulomatous Disease, Chronic

ArticleYear
Measurement of methemoglobin formation from oxyhemoglobin. A real-time, continuous assay of nitric oxide release by human polymorphonuclear leukocytes.
    Journal of immunological methods, 1995, Jul-17, Volume: 184, Issue:1

    Topics: Amino Acid Oxidoreductases; Catalase; Granulomatous Disease, Chronic; Humans; Leukocyte Count; Methe

1995